Meet the team: Leo James, Co-founder and Chief Scientific Adviser, TRIMTECH Therapeutics
Tell us more about your professional and academic career, how that led you to leading a research group at the MRC Laboratory of Molecular Biology, and co-founding TRIMTECH. After a degree in genetics, I obtained a PhD in structural biology and then undertook a postdoc in protein engineering with Sir Greg Winter. It was working […]
Meet the team: Andrea Testa, Senior Director of Chemistry
Could you tell us more about your academic and industry journey? What led you to pursue your postdoctoral research with Prof. Alessio Ciulli, co-founding Amphista Therapeutics, and how that path brought you to TRIMTECH as Senior Director of Chemistry. I joined Alessio’s research group over a decade ago, driven by an interest in developing chemistry […]
Presenting at RCS-BMCS Hot Topics: PROTACs and Glues 2025
Senior Director of Chemistry, Andrea Testa, is talking about our exciting platform at the RSC web event “RCS-BMCS Hot topics on PROTACs and Glues”. He is speaking alongside other leaders in the field of targeted protein degradation, including Prof. Alessio Ciulli. BMCS Hot Topics: PROTACs and Glues 2025
Leo James elected Fellow of the Royal Society
We are delighted to congratulate our academic co-founder, Leo James, on his election as a Fellow of the Royal Society. Being elected a Fellow of the Royal Society is one of the highest honours for a UK scientist, recognising exceptional contributions to science and offering prestigious validation, influence, and opportunity. https://www2.mrc-lmb.cam.ac.uk/leo-james-greg-jefferis-and-marta-zlatic-elected-to-royal-society/
Nicki Thompson talks with BiotechTV at BioTrinity 2025
Nicki Thompson, TRIMTECH Therapeutics Limited’s CEO, gave an oral presentation at BioTrinity 2025. In this post from BiotechTV she reviews the unique properties of TRIM21 that make it so powerful for selectively degrading protein aggregates while leaving soluble protein unaffected.

